Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.44 +3.45 (+31.35%)
As of: Sep 29, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Total Current Liabilities (2010 - 2026)

Updated

Iovance Biotherapeutics' Total Current Liabilities came in at $106.85 million for Q2 2026, down 17.3% from $129.16 million a year earlier and down 17.4% from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Iovance Biotherapeutics' Total Current Liabilities was $138.36 million, up 13.1% from FY2024.

  • Total Current Liabilities has increased in each of the last ten years, with a five-year compound annual growth rate of 20.3% (FY2020 to FY2025).
  • Going back by year, Total Current Liabilities was $122.34 million in FY2024 (+10.9%), $110.31 million in FY2023 (+20.6%), $91.49 million in FY2022 (+2.6%) and $89.2 million in FY2021 (+62.6%).
  • The Q2 2026 figure represents the lowest quarterly Total Current Liabilities since Q1 2024.
  • Year-over-year, Total Current Liabilities increased in four of the last five quarters, with growth averaging 11.9%.
  • The fastest year-over-year change in Total Current Liabilities over five years came in Q4 2021 (growth of 62.6%), and the weakest in Q2 2026 (a decline of 17.3%).
  • Business Quant data shows IOVA's Total Current Liabilities at $129.42 million (Q1 2026), $138.36 million (Q4 2025) and $125.79 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Iovance Biotherapeutics 4.98 Bn 3.77 Bn 55.72 Mn 106.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 106.85 Mn
Mar 31, 2026 129.42 Mn
Dec 31, 2025 138.36 Mn
Sep 30, 2025 125.79 Mn
Jun 30, 2025 129.16 Mn
Mar 31, 2025 122.69 Mn
Dec 31, 2024 122.34 Mn
Mar 31, 2024 83.21 Mn
Dec 31, 2023 110.31 Mn
Sep 30, 2023 90.96 Mn
Jun 30, 2023 88.64 Mn
Mar 31, 2023 87.27 Mn
Dec 31, 2022 91.49 Mn
Sep 30, 2022 79.25 Mn
Jun 30, 2022 64.19 Mn
Mar 31, 2022 77.08 Mn
Dec 31, 2021 89.20 Mn
Sep 30, 2021 64.77 Mn
Jun 30, 2021 60.53 Mn
Mar 31, 2021 55.06 Mn
API Access

Iovance Biotherapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=IOVA&period=max&api_key=YOUR_API_KEY